STOCKHOLM, Oct. 22, 2025 /PRNewswire/ — The Board of Directors of Boliden has, based on the authorization from the Annual General Meeting on 23 April 2025, resolved to repurchase a maximum of 130,000 shares on Nasdaq Stockholm during the period 22 October 2025 up to and including 24 October 2025 for a total amount of maximum… Continue reading Boliden resolves to repurchase its shares
Tag: Financial Results
Full Truck Alliance Co. Ltd. to Announce Third Quarter 2025 Financial Results on Monday, November 17, 2025
Earnings Call Scheduled for 7 :00 A.M. U.S. ET on November 17, 2025 GUIYANG, China, Oct. 22, 2025 /PRNewswire/ — Full Truck Alliance Co. Ltd. (“FTA” or the “Company”) (NYSE: YMM), a leading digital freight platform, today announced that it will release its third quarter 2025 unaudited financial results on Monday, November 17, 2025,… Continue reading Full Truck Alliance Co. Ltd. to Announce Third Quarter 2025 Financial Results on Monday, November 17, 2025
Jacobs Selected to Design UK’s Uxbridge Moor Substation
Project to enhance London’s electrical grid infrastructure and power supply reliability DALLAS, Oct. 22, 2025 /PRNewswire/ — Jacobs (NYSE: J) has been selected by Murphy as the civil design partner on the construction of Uxbridge Moor, a new substation in west London. The multimillion-pound contract from National Grid Electricity Transmission (NGET) will see the construction of a new substation… Continue reading Jacobs Selected to Design UK’s Uxbridge Moor Substation
EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion
Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agreement. ImCheck’s shareholders will be eligible to receive a payment of EUR 350 million and downstream payments, for a total potential consideration of up to EUR 1 billion. ImCheck Therapeutics is a private French biotechnology company pioneering next-generation immuno-oncology therapies. EQT Life Sciences has… Continue reading EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion
OMI wins the EV Design Excellence Award for its innovative hybrid Fusion Drive System
DETROIT, Oct. 21, 2025 /PRNewswire/ — OMI was honored to receive the EV Design Excellence Award at the 2025 Battery Show Expo in Detroit, MI. This honor highlights OMI’s investment in innovative, flexible hybrid technology, providing OEM’s with a customizable platform for their ICE vehicles and boats. OMI’s Fusion Drive hybrid powertrain is a durable solution… Continue reading OMI wins the EV Design Excellence Award for its innovative hybrid Fusion Drive System
ZTE hosts ZTE Broadband User Congress 2025 in Mexico City under the theme “AI Boosting Broadband Benefits”
MEXICO CITY, Oct. 22, 2025 /PRNewswire/ — ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, recently kicked off its 2025 Broadband User Congress in Mexico City, Mexico. This year’s congress themed “AI Boosting Broadband Benefits”, brought together over 400 global ICT industry leaders, top telecom operators, enterprise innovation pioneers,… Continue reading ZTE hosts ZTE Broadband User Congress 2025 in Mexico City under the theme “AI Boosting Broadband Benefits”
Research From IHL Group, with Scandit, Reveals Shelf Intelligence as Retail’s New Strategic Imperative
Inventory issues including out-of-stocks, overstocks and misplaced items remain a critical challenge for retailers, equating to $1.73 trillion in lost sales annually, hitting retailer profitability in tandem. Consequently, inventory visibility ranks second as a technology investment priority behind personalization of the customer experience, according to the research. However, retailers with profit growth of 10%+ are… Continue reading Research From IHL Group, with Scandit, Reveals Shelf Intelligence as Retail’s New Strategic Imperative
Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology
TOKYO, Oct. 22, 2025 /PRNewswire/ — Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; “Renalys”) is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese Society for Pediatric Nephrology (Head Office: Chiyoda-ku, Tokyo). The study is headed by Professor Kandai Nozu, Department of Pediatrics, Graduate School of… Continue reading Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology
Boliden Q3 2025: Strong cash flow and solid mine production
STOCKHOLM, Oct. 22, 2025 /PRNewswire/ — “Overall, the results for the quarter were strong. We had a significant cash flow, even though major investments are still ongoing primarily in the Boliden Area, Odda and Rönnskär.” – Mikael Staffas, President and CEO. Financials Revenues: SEK 21,971 m (22,193) Operating profit: SEK 3,237 m (3,165) Operating profit excl. PIR*: SEK… Continue reading Boliden Q3 2025: Strong cash flow and solid mine production
Aker BP reports third quarter 2025 results
LYSAKER, Norway, Oct. 22, 2025 /PRNewswire/ — Aker BP delivered another strong quarter in Q3 2025, demonstrating operational excellence, disciplined cost control, and continued progress on key growth projects. Production remained stable, supported by high uptime and safe execution across the portfolio. The company achieved a major milestone with the Omega Alfa oil discovery in… Continue reading Aker BP reports third quarter 2025 results